RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

LOS ANGELES and AMSTERDAM, April 24, 2024 -- Renovaro Inc. , a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensitive 4th generation...

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,Holland ,Henk Vi ,Alessio Marcozzi ,Cyclomic Omniomics ,Oxford Nanopore ,Renovaro Bio ,Health Holland Venture ,Renovaro Inc ,Nasdaq ,Oxford Nanopore Technology ,Nvidia ,Chief Commercial Officer ,Artificial Intelligence ,Health Holland Venture Challenge ,Disrupt Cancer Diagnosis ,Annual Report ,